Diabetic foot ulcers (DFUs) are a major clinical challenge, with high rates of morbidity, disability, amputations and ...

In patients with diabetic wounds, copper oxide impregnated dressings were noninferior to standard negative pressure wound therapy.

A simple stress ball has been shown to significantly reduce anxiety and pain during sharp debridement commonly used in nursing homes to promote wound healing.

MediWound publishes analysis showing EscharEx® outperforms SANTYL® in treating venous leg ulcers, highlighting faster debridement and ... in VLUs and a clinical study for diabetic foot ulcers.

MediWound, partly backed by the Point72 hedge fund founded by New York Mets baseball team owner Steve Cohen, is also preparing for a Phase II/III clinical trial targeting diabetic foot ulcers ...

MediWound has commenced a pivotal, multicentre Phase III VALUE trial to assess its bioactive debridement therapy, EscharEx, for treating venous leg ulcers (VLUs). The primary aim of the trial is ...

World Diabetes Day 2024: Here's how diabetic foot diseases and foot ulcers are caused, who is at risk, signs to watch and expert tips to prevent or manage them | Health ...

SINGAPORE – Having diabetes often means having slow-healing wounds like chronic diabetic foot ulcers. With more than half a billion people living with diabetes worldwide and that number ...